All Stories

  1. Thinking outside the box to reduce health inequities in prenatal nicotine and tobacco exposure
  2. Association between smoking status and changes in health behaviours during the COVID-19 lockdown: a cross-sectional study in Israel
  3. “What can I do? fight him?” Perceptions and Experiences in Reducing Secondhand Smoke Exposure During Pregnancy: A Qualitative Study Among Israeli Women
  4. Qualitative Examination of US and Israeli Adults’ Perceptions of IQOS Advertising Messages: Modified Exposure and Risk Statements, US FDA Endorsement, and Health Warnings
  5. Israeli dentists’ knowledge, attitudes, and practices regarding smoking cessation care
  6. Differences and interactions between intrinsic and extrinsic motivations that drive smokers to quit and to continue smoking: a qualitative analysis
  7. Israeli smoking cessation practitioner’s knowledge, attitudes and practices regarding electronic cigarettes
  8. IQOS point-of-sale marketing: a comparison between Arab and Jewish neighborhoods in Israel
  9. IQOS news media coverage in Israel: a comparison across three subpopulations
  10. Low compliance and proliferation of IQOS purchase cues at points-of-sale: a comparative study before and after Israel’s display ban
  11. Israeli Dentists’ Knowledge, Attitudes, and Practices Regarding Smoking Cessation Care
  12. Promotion of legume intake—Israeli dietitians’ knowledge, beliefs and practices
  13. Perceptions of Heated Tobacco Products (HTPs) Versus Cigarettes and e-Cigarettes in Relation to Likelihood of Trying HTPs or Suggesting HTPs to Those who Smoke Cigarettes
  14. Driving under the influence of cannabis versus alcohol: A mixed-methods study examining perceptions and related risk behaviors among US and Israeli adults
  15. Barriers and Enablers to Implementing a Smoke-free Home and Car During Pregnancy: A Qualitative Study Among Expectant Israeli Fathers
  16. IQOS Marketing Strategies and Expenditures in the United States From Market Entrance in 2019 to Withdrawal in 2021
  17. Industry marketing of tobacco products on social media: case study of Philip Morris International’s IQOS
  18. ‘A war of a different kind’: local municipalities’ experiences in managing the COVID-19 pandemic in Israel–a qualitative study
  19. IQOS Use and Interest by Sociodemographic and Tobacco Behavior Characteristics among Adults in the US and Israel
  20. “It Needs a Full-Time Dedicated Person to Do This Job in Our Local Communities with Our Aboriginal Health Services”—Aboriginal and Torres Strait Islander Health Workers and Practitioners Perspectives on Supporting Smoking Cessation during Pregnancy
  21. Impact of FDA endorsement and modified risk versus exposure messaging in IQOS ads: a randomised factorial experiment among US and Israeli adults
  22. PMI’s IQOS and cigarette ads in Israeli media: a content analysis across regulatory periods and target population subgroups
  23. IQOS and cigarette advertising across regulatory periods and population groups in Israel: a longitudinal analysis
  24. Which Way?Indigenous-led Smoking Cessation Care: Knowledge, Attitudes and Practices of Aboriginal and Torres Strait Islander Health Workers and Practitioners – A National Cross-sectional Survey
  25. Unclear role for e-cigarettes during pregnancy
  26. IQOS marketing strategies at point-of-sales: a cross-sectional survey with retailers
  27. Changes in Smoking Behavior, Stress, and Sleep Duration Among Israeli Hospital Workers During the COVID-19 Pandemic: A Cross-sectional Study
  28. Proximity of IQOS and JUUL points of sale to schools in Israel: a geospatial analysis
  29. IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation
  30. IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers
  31. Assessment of IQOS Marketing Strategies at Points-of-Sale in Israel at a Time of Regulatory Transition
  32. Changes in Smoking Behaviour and Home-Smoking Rules during the Initial COVID-19 Lockdown Period in Israel
  33. Feasibility of Audio-Recording Consultations with Pregnant Australian Indigenous Women to Assess Use of Smoking Cessation Behaviour Change Techniques
  34. Ngaa-bi-nya-nhumi-nya (to Test First): Piloting the Feasibility of Using the Growth and Empowerment Measure with Aboriginal Pregnant Women Who Smoke
  35. Commentary on Simons et al. Public health implications of the suggested association between nicotine, smoking and infection with SARS‐CoV‐2
  36. Pregnant Aboriginal women self-assess health risks from smoking and efficacy to quit over time using an adapted Risk Behaviour Diagnosis (RBD) Scale
  37. A nationwide assessment of lifestyle medicine counseling: knowledge, attitudes, and confidence of Israeli senior family medicine residents
  38. Tobacco legislation reform and industry response in Israel
  39. IQOS point-of-sale marketing strategies at a time of legislation transition in Israel
  40. Tobacco industry tactics in response to extensive tobacco control legislation in Israel
  41. General practitioner and obstetrician views on system changes to improve smoking cessation care in pregnancy in Australia: a cross-sectional survey
  42. Historic tobacco legislation in Israel: a moment to celebrate
  43. Informing iQOS Regulations in the United States: A Synthesis of What We Know
  44. Association Between Prenatal Smoking and Gestational Diabetes Mellitus
  45. Feasibility of audio-recording consultations with pregnant Australian Indigenous women to assess use of smoking cessation behaviour change techniques
  46. What components of smoking cessation care during pregnancy are implemented by health providers? A systematic review and meta-analysis
  47. Feasibility of a text-messaging smoking cessation program for soldiers in Israel
  48. Improving health providers smoking cessation care for Aboriginal pregnant women: a pilot trial
  49. Improving health providers smoking cessation care in pregnancy: A systematic review and meta-analysis
  50. Aboriginal Wingadhan Birrang (woman’s journey) of smoking cessation during pregnancy as they participate in the ICAN QUIT in pregnancy pilot step-wedge trial
  51. Feasibility and acceptability of Indigenous Counselling and Nicotine (ICAN) QUIT in Pregnancy multicomponent implementation intervention and study design for Australian Indigenous pregnant women: A pilot cluster randomised step-wedge trial
  52. Overcoming Challenges to Treating Tobacco use During Pregnancy - A Qualitative study of Australian General Practitioners Barriers
  53. IQOS point-of-sale marketing strategies in Israel: a pilot study
  54. Ngu-ng-gi-la-nha (to exchange) knowledge. How is Aboriginal and Torres Strait Islander people's empowerment being upheld and reported in smoking cessation interventions during pregnancy: a systematic review
  55. Giri-nya-la-nha (talk together) to explore acceptability of targeted smoking cessation resources with Australian Aboriginal women
  56. Building Capacity for Global Tobacco Treatment: International Frontline Provider Perspectives
  57. Nicotine replacement therapy for smoking cessation during pregnancy
  58. Do Clinicians Ask Pregnant Women about Exposures to Tobacco and Cannabis Smoking, Second-Hand-Smoke and E-Cigarettes? An Australian National Cross-Sectional Survey
  59. Clinician factors associated with prescribing nicotine replacement therapy in pregnancy: A cross-sectional survey of Australian obstetricians and general practitioners
  60. Assessing and Validating an Educational Resource Package for Health Professionals to Improve Smoking Cessation Care in Aboriginal and Torres Strait Islander Pregnant Women
  61. Designing an implementation intervention with the Behaviour Change Wheel for health provider smoking cessation care for Australian Indigenous pregnant women
  62. The Indigenous Counselling and Nicotine (ICAN) QUIT in Pregnancy Pilot Study protocol: a feasibility step-wedge cluster randomised trial to improve health providers' management of smoking during pregnancy
  63. Opportunities Missed: A Cross-Sectional Survey of the Provision of Smoking Cessation Care to Pregnant Women by Australian General Practitioners and Obstetricians
  64. Lifestyle medicine course for family medicine residents: preliminary assessment of the impact on knowledge, attitudes, self-efficacy and personal health
  65. Smoking Behavior Change During Compulsory Military Service in Israel, 1987–2011
  66. Collective and negotiated design for a clinical trial addressing smoking cessation supports for Aboriginal and Torres Strait Islander mothers in NSW, SA and Qld – developing a pilot study
  67. Receiving family physician’s advice and the ‘stages of change’ in smoking cessation among Arab minority men in Israel
  68. Risk of Hodgkin lymphoma according to immigration status and origin: a migrant cohort study of 2.3 million Jewish Israelis
  69. Evaluating the Need for Palliative Care Services at a General Hospital in Israel
  70. Smoking initiation among Israeli adolescents: A 24-year time-to-event analysis
  71. Time trends of viral meningitis among young adults in Israel: 1978–2012
  72. Smoking and Other Correlates of Health Care Services Utilization Among Mandatory Military Recruits in Israel
  73. Secular trends of gonorrhea in young adults in Israel: three decades of follow-up
  74. Preventive effect of meningococcal vaccination in Israeli military recruits
  75. Post exposure prophylaxis of tick-borne relapsing fever
  76. Trends in the epidemiology of cutaneous leishmaniasis in a young adult population in Israel: a long-term survey
  77. A Cluster of Ecthyma Outbreaks Caused by a Single Clone of Invasive and Highly InfectiveStreptococcus pyogenes
  78. Immunity to Varicella Zoster Virus Among Young Adults: A Decline Prior to Widespread Uptake of Varicella Vaccines
  79. Disease-Modifying Effects of Postexposure Hepatitis A Active Immunization
  80. Identification of Risk Factors for Infection in an Outbreak of Mycoplasma pneumoniae Respiratory Tract Disease
  81. “Bread madness” revisited: screening for specific celiac antibodies among schizophrenia patients